Showing results (361-370 of 391) with videos related to
Sort By:
Pageof 40
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2018
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovirMauro Viganò, Alessandro Loglio, Sara Labanca, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid AnalysesAndrea Pilotto, Stefano Masciocchi, Irene Volonghi, et al.Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.Journal of Travel Medicine|December 17, 2019
Schistosomiasis, strongyloidiasis and Chagas disease: the leading imported neglected tropical diseases in ItalyLorenzo Zammarchi, Federico Gobbi, Andrea Angheben, et al.Elife|March 2, 2021
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control studyChiara Fallerini, Sergio Daga, Stefania Mantovani, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2020
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" StudyAndrea Gori, Andrea Antinori, Alessandra Vergori, et al.Clinical and Experimental Rheumatology|May 19, 2017
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants todayFilippo Bartalesi, Carlo Scirè, Ana Requena-Méndez, et al.Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.Journal of Personalized Medicine|July 2, 2021
Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic VariantsMargherita Baldassarri, Francesca Fava, Chiara Fallerini, et al.Pageof 40